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1HIFU Power Monitoring Using Combined
Instantaneous Current and Voltage Measurement
Chris Adams, James R. McLaughlan, Thomas M. Carpenter, and Steven Freear
Abstract—During HIFU therapy it is important that the
electrical power delivered to the transducer is monitored to
avoid under or over exposure, ensure patient safety and to
protect the transducer itself. Due to ease of measurement, the
transducer’s potential difference may be as an indicator of
power delivery. However, even when a transducer’s complex
impedance is well characterised at small amplitudes and match-
ing networks are used, voltage-only (VO) monitoring cannot
account for the presence of drive waveform distortion, changes
to the acoustic path or damage to the transducer. In this study,
combined current and voltage (CCV) is proposed as an MRI-
compatible, miniature alternative to bi-directional power couplers
that is compatible with switched amplifiers. For CCV power
measurement, current probe data was multiplied by the voltage
waveform and integrated in the frequency domain. Transducer
efficiency was taken into account to predict acoustic power.
The technique was validated with a radiation force balance
(RFB). When using a typical HIFU transducer and amplifier,
VO predictions and acoustic power had a maximum difference
of 20%. However, under the same conditions, CCV only had a
maximum difference of 5%. The technique was applied to several
lesioning experiments and it was shown that when VO was used
as a control between two amplifiers there was up to a 38%
difference in lesion area. This greatly reduced to a maximum of
5% once CCV was used instead. These results demonstrate that
CCV can accurately predict real-time electrical power delivery
leading to safer HIFU treatments.
I. INTRODUCTION
H IGH intensity focused ultrasound (HIFU) is a surgicaltechnique that is used to generate necrosis in tissue via
thermal [1], [2] or other mechanical effects such as cavitation
[3], [4] or boiling [5]–[7]. The technique is highly localised,
and it can be used to non-invasivley treat an area while sparing
surrounding tissue. The main application area of HIFU is the
treatment of soft tissue tumours [8], [9] in liver [10], kidney
[11], prostate [12], [13], breast [14] and in the brain [15]–[19].
Magnetic resonance imaging (MRI) is frequently used to
guide HIFU to provide real-time temperature maps [20]. Many
thousands of patients worldwide have benefited from the
combination of these technologies for treatment of uterine
fibroids and bone tumours [21].
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For ultrasound imaging systems, the focus of electronics
research has largely been on improving computational power
and element count [22]. However, for HIFU systems where
the continuous power ratings must be significantly higher [23],
the focus has been on reducing the cost, size and complexity
[24], [25] whilst maintaining MRI compatibility [26], [27].
The exception is transcranial systems where the element count
continues to increase due to improved steering capabilities
[16], [28]–[30]
When making thermally-formed lesions using HIFU, the
total acoustic power is arguably the most critical value as it
dictates the spatial-peak pulse-average intensity (ISPPA) and
spatial-peak temporal-average (ISPTA), which both correlate
with lesion volume (the latter being a better metric of heating
for low duty cycle exposures [31]). If excessive power is
applied, the transducers could be damaged [23] or worse
yet, the patient’s tissue could be heated to potentially fatal
temperatures. If underexposure occurs, the treatment may
result in failure. Systems therefore must be calibrated so the
acoustic power and thus intensity can be reliably controlled
[24].
The international standards recommend calculating the
spatial-peak pulse-averaged intensity from free-field measure-
ments made using a hydrophone [32]. Damage thresholds
and bandwidth limitations of regular hydrophones along with
propagation nonlinearities [7] make measurement of these
fields at clinically relevant intensities impossible. Therefore,
for regular hydrophones, the recommendation is to take mea-
surements under quasi-linear conditions and scale them with
drive voltage to predict intensity values at higher powers [32].
Several authors have suggested using fibre optic hydrophones
instead, which have much higher damage thresholds and can
therefore be used to measure the subtle variances in intensity
due to nonlinear propagation [33], [34]. Measurements using
hydrophones must be performed at low duty cycles. For higher
intensities and duty cycles, the radiation force balance (RFB)
is the gold standard. It provides total acoustic power and
spatial-average intensity if the beam dimensions are known
[32]. However, both hydrophone and RFB measurement must
be made in the free field before an exposure and can make
no guarantees for patient safety during therapy. Therefore, a
technique that can monitor power delivery during a HIFU
exposure is highly desirable.
In this paper, the feasibility of using combined current and
voltage (CCV) to measure effective power and thus predict
acoustic power from the efficiency will be assessed.
2II. CURRENT METHODOLOGIES
When the drive frequency of a voltage source is DC (ie
f = 0 Hz), Ohm’s law may be used to calculate the current
flowing from the source to a load (I = V/R) and total power
dissipation in a load (P = I2R). However, when the voltage
source has a non zero frequency (AC), the resistance R of the
load must instead be substituted with the complex impedance
Z. It is also common place to use RMS rather than peak
values for voltage, current and power, so that power (S) can
be represented by
S = V 2/‖Z‖ (1)
If the impedance phase angle (ϑ) is low, then active power (P )
can be considered to be approximately the same as apparent
power:
S ≈ P if ϑ < ǫ (2)
This may prove accurate enough for simple experiments and
some studies [33].
To reduce the phase lead/lag, HIFU transducers are com-
monly connected to their driving circuit via a matching net-
work of capacitors, inductors, and sometimes resistors [35].
By ensuring that the impedance matches the source as closely
as possible, energy conversion in the transducer, at the cost of
bandwidth, can be maximised [36]. However, the bulkiness of
matching networks make them unsuitable for dense array ap-
plications (>1000 elements), so other techniques are explored
to reduce the impedance of transmitting elements [37]. Arrays
may also include purposely non-uniform elements where the
impedance varies significantly across the array [38].
If the phase angle cannot be made trivially small (ϑ > ǫ),
the complex rather than mangnitude of the impedance may be
included in the calculation to extract the active, ie dissipated
power in the load [39]. Although calculating dissipated power
in this way may be suitable for simple loads at low frequencies
(< 1 KHz), HIFU transducers are high frequency (≈ 1
MHz), complex electro-mechanical devices where impedance
is greatly influenced by the acoustic path. The material proper-
ties of the propogation medium [40], the presence of acoustic
reflectors (eg bone), cavitation [41] and saturation [23] are all
known to influence impedance.
Switched circuits, which are highly desirable alternatives to
linear amplifiers, due to their improved efficiency and reduced
size [19], [42], conduce harmonic distortion. Even minor
harmonics generated by these circuits, greatly influence the
voltage signal due to the frequency-varying reactance of the
source and load impedances. Matters are further complicated
by the fact that voltage may be reflected from the load back to
the source, and that both source and load impedances can vary
significantly with frequency. For these reasons, even accurate
impedance measurements and matching networks (if space
even allows) do not predicate the use of voltage-only (VO)
to predict acoustic power accurately. VO therefore is not an
accurate way to predict acoustic power and the inadequacies of
using impedance and VO to predict acoustic power are known
[43].
One method of measuring effective power is to use bi-
directional power couplers [24], [42], [44], which consist of
transformers attached to transmission lines. These couplers
produce two voltage signals proportional to the forward and
reflected power. The Sonalleve MR-HIFU system (Philips
Healthcare, Netherlands) uses this technique. Due to the
varying impedance of the transducer and the pulsed-wave
operation of HIFU it may be necessary to use additional
equipment to extract the peak, average and frequency-varying
power. Their use of ferrous materials and insertion losses make
them suboptimal for use in MRI guided array applications.
The physical size of these couplers make them an untenable
solution for dense transcranial arrays. Couplers could be re-
located away from the MRI machinery and transducers, but
this induces errors as cable length may be responsible for as
much as 50% of power usage [45] and if the transducers are
not well matched, further errors may be introduced [42], [46].
Authors have already presented work on using current
measurements to predict acoustic power (if the efficiency is
known), however techniques proposed so far are not immune
to harmonic distortion [47]. In this study we will augment
this original work by testing both switched and linear am-
plifiers and observing the effects of two power measurement
techniques on lesion formation.
III. PROPOSED METHODOLOGY
To measure active (dissipated) power, the time varying RMS
voltage and current values are transformed into the frequency
domain using an FFT and multiplied together:
S(f) = V (f)× I(f)∗ (3)
The complex conjugate of I(f) is used so that a leading
current results in negative reactive power. The real component
of S(f) is integrated between two bounds:
Ptotal =
∫ f1
f0
Re{S(f)}df
f1 − f0
(4)
The values of f0 and f1 should be chosen to include
any signal greater than -20 dB. Where 0 dB refers to the
peak magnitude of Re{S(f)}. For example, with a 1.1 MHz
SonicConcepts H-102 HIFU transducer that has been widely
used in a number of pre-clinical studies, this equates to f0 =
0.5 MHz and f1 = 5 MHz. The values of f0 and f1 are
chosen so that the integration is significantly more broadband
than the device’s centre frequency. Making the bandwidth
large improves the accuracy because harmonics generated by
the drive circuit or device are included. The bounds must be
limited however so as to reject cumulative high frequency
noise. The -20 dB threshold was chosen heuristically to give
accurate results. I(t) can be obtained via a current probe, or
current shunt and differential amplifier. The current along with
V (t) may be captured by a data acquisition Oscilloscope. An
FFT should be used to transform the data into the frequency
domain. Ptotal represents the total active power in Watts.
The total acoustic power (also in Watts), W then is simply
η × Ptotal, where η is the efficiency of the transducer.
3IV. VALIDATION WITH RADIATION FORCE BALANCE
The technique was first validated using a radiation force
balance (Precision Acoustics Ltd, UK). Two common single
element focused HIFU transducers (H102, Sonic Concepts,
USA) and a 10-strip, segmented array transducer (M102-065,
Immasonic, France) were tested.
All transducers are manufactured from PZT. The 10-strip is
11 cm in diameter, with a 5 cm bore for an imaging array.
It has a focus of 15 cm and is linearly segmented into 10
strips across the diameter of the transducer. More details on
the manufacture of the 10-strip can be found in [48]. The
diameter of the H102 transducers are 64 mm and their focal
distance is 63 mm. At the time of the experiment, one of
the H102 transducers was 6 months old and had been excited
for less than 1 hour totally in its lifetime (H102-079). The
older of the two was 6 years old and had been excited for
approximately 6 hours totally in its lifetime (H102-065). The
distinction is made so that the effects of degradation can be
considered. They were otherwise identical.
All of the transducers were used with their manufacture-
provided matching networks. The impedance of all three
transducers were measured in water using a short cable and an
impedance analyser (Bode 100, Omicron, USA). For the 10-
strip, the matching network simply combines all the elements
in parallel, so that the impedance was 50Ω, ϑ ≈ 0 at 1
MHz. The H102 transducers use a transformer based matching
network, so that the impedance was 50Ω, ϑ ≈ 0 at 1.1 MHz.
While the 10-strip is most effective at 1.0 MHz it has a
broad bandwidth so is usually driven at 1.7 MHz to increase
absorption in tissue [41]. At 1.7 MHz, the impedance was
approximately 7Ω, ϑ = 17◦.
All of the HIFU transducers were driven by a typical linear
amplifier (100A400AM6, AR RF/Microwave Instrumentation,
USA). A signal generator (33250A, Keysight Technologies
UK Ltd, Berkshire, UK) was connected to the input of the am-
plifier. A current probe (TM502A, Tektronix Inc., USA) was
clamped around the positive input of the associated matching
network to measure current flowing between the transducer
and the amplifier. The probe amplifier was set to 50mA
per 10mV. The voltage across the matching network was
simultaneously measured using an oscilloscope (WaveRunner,
LeCroy, USA). Time delays due to cable lengths were cal-
ibrated out using a purely resistive 50 Ω load. A total of
1000 cycles from the oscilloscope were saved for the purposes
of averaging. The oscilloscope sampling frequency was 200
MHz. The electrical connections used are shown in the grey
box of figure 1.
For the radiation force balance (RFB), a 10 cm diameter
calibrated absorber (Precision Acoustics Ltd, UK) was sus-
pended in water from a set of high precision scales. Degassed,
deionised water was used which was allowed to rest for 30
minutes so that the temperature was close to that of the
room (23 ◦C). The transducer was mounted concentric to
the absorber at a distance where it encompassed all of the
acoustic energy but remained in the pre-focal region. This
was approximately 2 cm for the H102s and 5 cm for the 10-
strip. For each test, the off-on-off cycle of acoustic power was
measured four times. Three measurements made up each off-
on-off cycle: moff1 with the transducer de-energised, mon 10
seconds into the transducer being energised and moff2 10 sec-
onds after the transducer had been de-energised. In accordance
with the manufacturer’s recommendations for making accurate
measurements, the loss of water by evaporation above the
target was compensated for by using the mean mass difference
of each measurement. This was calculated as follows:
m =
(mon −moff1) + (mon −moff2)
2
(5)
m was then averaged over the 4 repeats and the following
equation was used to calculate the power:
W = mcgF (6)
W is the total acoustic power in Watts, c is the speed of sound,
g is the gravitational constant and F is the calibration factor
(0.95-1), which was established by a measurement standards
laboratory (National Physical Laboratory, London, UK) and
described the input/output power ratio of the target. cgF ≈
14.5 mWmg−1.
The scales, signal generator and oscilloscope were all con-
nected to a computer to automate the measurement. To test the
scheme across a range of acoustic powers, the signal generator
was programmed by a laptop computer to produce waveforms
with a peak to peak voltage between 25mV and 350mV in
intervals of 25mV. Given the geometry of the transducer and
the gain of the amplifier, 350mV corresponds approximately
to a peak positive pressure of 8.72 MPa and a peak negative
pressure of 7.00 MPa.
Active electrical power was measured in two ways (a)
using voltage-only and the complex impedance (Re{V 2/Z})
and (b) by using the proposed technique. Measurement were
performed simultaneously. The measured electrical powers
were compared against the actual achieved acoustic powers
for all three transducers.
Additionally, using only the H102-079 transducer, the ro-
bustness of the scheme to harmonic distortion in the drive
waveform was tested. This was achieved by exciting the
transducer using a square wave. The purpose of this was
to simulate harmonic distortion brought about by a switched
circuit (eg class D). This was done to ascertain whether the
harmonic distortion influenced the reliability of voltage as a
control.
V. THERMAL LESION STUDY
The CCV method can predict acoustic power irrespective of
the relationship between source and load impedance. In this
second study, the impact of this on lesion formation was as-
sessed. To do this, the lesioning efficacy of a switched system
was compared with a linear amplifier system. Lesions were
made using the older of SonicConcepts transducer (H102-
065) at electrical powers of 16 and 26 W. Using a reported
efficiency of 70%, and an estimation of the beam width
(1.3mm) these should correspond approximately to spatial-
average pulse-average intensities of 843±148 and 1371±238
W cm−2 respectively. A reduction in electrical power should
reduce the lesion volume and if the power monitoring scheme
4TABLE I
SYSTEM SETTINGS TO ACHIEVE DESIRED ACOUSTIC POWER USING
VOLTAGE ONLY (*) AND COMBINED CURRENT AND VOLTAGE
CALIBRATIONS
Power [W] HIFUARP [%] Signal gen. [mV]
16 68 195
16(*) 65 208
26 84 260
26(*) 85 240
is effective, the lesion volumes should be similar irrespective
of the excitation circuit used for a given electrical power.
For the linear amplifier experiments, a signal generator
(33600A, Agilent, USA) was connected to a 45 dB linear
power amplifier (A150, E&I Ltd, USA) (figure 1). This am-
plifier was chosen over the one used in the previous study due
to the continuous power ratings being higher. For the lesions
made with a switched circuit, the High Intensity Focused
Ultrasound Array Research Platform (HIFUARP) was used
[25]. The switched system had voltage rails that were set to
asymmetric values to compensate for the different resistances
of the P and N channel MOSFETs, such that the maximum
and minimum possible voltage values were ±68 V. The 5-
level HRPWM modulation algorithm was used to design the
switched waveforms [49]. The current and voltage at the input
of the matching network was monitored as described in the
previous section.
Each system was calibrated to produce the same acoustic
intensity in two ways. The first set of lesions were formed
when both systems were calibrated using the active power
calculated using voltage-only and impedance. The second set
of lesions were formed when both systems were calibrated
using CCV (the proposed technique). For each calibration
technique, at both powers, three lesions were made, leading
to a total of 24 lesions. The results of each calibration are
shown in table I. The HIFUARP system uses PWM to drive the
transducer, so it’s values represent pulse-width. At 100% the
waveform is a perfect square wave, but at lower percentages
the waveform uses additional levels to better approximate
a sine wave. Hence as the amplitude changes the relative
distortion of the waveform also changes. The table shows
that since harmonic distortion cannot be guaranteed across
amplitudes, pulse width does not scale linearly with acoustic
power. The signal generator column represents the magnitude
of the input stage to the linear amplifier.
Ex vivo chicken breast was used as a tissue mimic for
the lesioning study. Fresh tissue was exposed to ultrasound
within 18 hours of purchase and was refrigerated at 4 ◦C
when not used. The samples were cut into cubes approximately
55 mm× 55 mm× 40 mm. The samples were then degassed
in a 1% (v/v) phosphate buffer solution for 4 hours. To ensure
repeatability between samples, they were placed in a holder
marginally smaller than their cut size so that they were slightly
compressed in all directions. The sample holder had acoustic
windows on opposite sides of approximately 50 mm×50 mm
(figure 1).
The sample holder was attached to a CNC machine stage. To
co-locate the centres of the transducer focus and the samples,
an alignment target was temporarily attached to the inside of
the sample holder, prior to the start of the first exposure. Using
a hydrophone (Y-107, Sonic Concepts, USA) co-located and
confocal with the centre of the HIFU transducer, the transducer
focus was pulse-echo positioned onto the target. The CNC
stage was programmed to move to 5 fixed locations spaced
20mm apart. This meant that the 5 lesions were always made
in the same locations and at a fixed depth of 20mm in each
sample. Sonications were performed in a tank of degassed,
deionised water which was maintained at 28± 1 ◦C using an
immersion circulator. Although lower than the normothermia
temperature of 37◦ C, this temperature was chosen to be
representative of in vivo tissue without causing premature
denaturing of the sample.
To attenuate post-focal energy and prevent reflections,
10mm of absorbing material was placed behind the samples.
The opening of the sample holder was significantly larger
than the focus and the transducer was placed in the centre
of the tank to reduce the risk of reflections influencing
acoustic propagation. The samples were sonicated for 20 s,
and between exposures, the tissue was allowed to cool for
10 s. The experiment schematic is depicted in figure 1.
Immediately after all the exposures were complete, samples
were sliced through the centre of the lesions, revealing two
halves of each lesion. Photographs of each lesion were taken
next to a ruler and an identifying code. Using image analysis
software (ImageJ, National Institutes for Health, USA), the
pixel/size ratio was calculated and then the lesion cross section
area was measured using an ellipse area tool. Lesions cross
section areas were then compared.
For the lesioning efficacy of different calibration schemes
to be compared we aimed to ensure that damage to the tissue
was predominantly thermal in nature and not from mechanical
effects such as acoustic cavitation and/or boiling [50]. Three
measures were taken to ensure that mechanical damage was
reduced. Firstly, a threshold-based passive cavitation detector
(PCD) system was used [25], [50]. Secondly, exposure times
and intensities within the limits of previously published lesion-
ing work (in chicken breast) were used [51]. Thirdly, lesions
were inspected for unusual shapes that may suggest boiling.
To ensure that each tissue sample was adequately degassed,
prior to lesion formation, a high amplitude (p ≈ 2 MPa)
5 cycle pulse was applied to the transducer to discount the
presence of bubbles. It was expected that the presence of
bubbles would have a harmonic response and therefore trigger
the PCD. Lesions where cavitation activity occurred were
discarded and not included in further analysis.
VI. RESULTS
Figure 2 shows the difference between measured acoustic
power (from RFB) and predicted power (electrical power ×
efficiency) for each transducer. When the difference is zero,
the predicted acoustic power (electrical power × efficiency)
matches actual acoustic power perfectly. When the error is pos-
itive the predicted power is higher than the acoustic power and
vice versa. The blue lines represent the H102-079 transducer
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Fig. 1. Schematic of the experimental apparatus used in this study. Not shown:
CNC machine. The grey box highlights the electrical connections that were
common between the validation and lesioning experiments.
while the H102-065 is represented by the green lines. The
10-strip is represented by the red lines. Here and in figure 3,
the dashed lines represent power predictions using VO, while
CCV (the proposed technique) is represented by the solid lines.
Inset is the same data but on a large y axis, to make the 10-
strip VO-measured power data visible. Figure 3 shows the
difference for both electrical excitations. The power obtained
using the sine waves and square waves are represented by the
blue and red lines respectively. For both figures, values for
efficiency (η) were obtained using values from the transducer
datasheets (75% for the H102s and 85% for the 10-strip). The
actual exact value of efficiency is not critical since the aim of
the measurement technique is to be as reliable as possible, ie,
produce the least variation in power across a range of acoustic
powers.
Figure 4 shows the lesion cross-sectional areas obtained
when using voltage-only (*) and CCV (the proposed tech-
nique) to calibrate the electrical powers. The lesions formed
by the linear amplifier are represented by the blue bar, while
the switched circuit system’s lesions are represented by green
bars. The red bars show the absolute difference in mean lesion
size between the systems. The error bars represent the standard
deviation of the three measurements, where each measurement
corresponds to a new lesion formed and measured by the same
operator.
Statistical tests were undertaken on the data. Firstly, each
set of repeats were tested for normality using the Shapiro-
Wilk test which is ideal for small sample sizes [52]. All sets
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Fig. 2. Difference between the acoustic power (obtained from a RFB) and
electrical power (once efficiency is accounted for). The electrical power was
measured using CCV (the proposed technique, solid line) and using voltage
only (dashed line). Three transducers were considered, a new H102 transducer
(blue line), an old H102 transducer (green line) and a 10-strip transducer (red
line). Only the first 50 Watts are shown. Inset: Same data zoomed out, to a
larger axis which makes the 10-strip’s data visible. Not shown: Measurement
error corresponds to about ±6%.
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Fig. 3. Difference between the acoustic power (obtained from a RFB) and
electrical power (once efficiency is accounted for). Two different excitation
schemes were tested, square wave (red) and a sinusoidal wave (blue). The
solid lines represent CCV-measured power, and the dashed lines represent
VO-measured power. Tested with H102-079 only. Not shown: Measurement
error corresponds to about ±6%.
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Fig. 4. Thermal lesion cross-section areas obtained in using a linear amplifier
and using a switched circuit. Lesions were made using electrical powers of
16 W and 26 W. Lesions formed when the circuits were calibrated using
power calculated from impedance and voltage are indicated by *. In the
other instances, the circuits were calibrated using current and voltage (CCV)
measurements. The red bars represent the absolute difference between the
lesion sizes.
TABLE II
RESULTS OF STATISTICAL TESTS PERFORMED ON LESION DATA
Power [W] pav σsw − σlin
16 0.55 +10%
16(*) 0.13 -38%
26 0.72 +4.9%
26(*) 0.06 +25%
of repeats did not reject the null hypothesis (psw > 0.05)
except for the lesions produced using the linear amplifier
at 16(*) W (psw < 0.05). Analysis of variance (ANOVA)
was then performed on the data. Despite the normality test
rejecting the null hypothesis on some of the data, the analysis
was still undertaken as ANOVA has high immunity to non-
normality and the probability of non-normality was close to
the threshold.
ANOVA was performed to assess similarity between
schemes at the same power and calibration technique (pav).
The results of the statistical tests made on the lesion data are
given in table II.
VII. DISCUSSION
With the efficiency of the transducers taken into considera-
tion, the difference between the predicted acoustic power and
actual acoustic power varied between -20% and -9% when the
proposed scheme was not used (fig. 2). Conversely when the
proposed scheme was used the variation was between only
-5% and +3%. For the 10-strip transducer, again using only
voltage, the difference began at 128% and increased rapidly
to a maximum of 304% which can likely be attributed to
reflections from transmission line effects. Using the proposed
scheme, the difference was between only 1% and 4% over the
same range of acoustic power.
Good matching of the H102 transducers and amplifier were
verified using a impedance analyser (Bode 100, Omicron,
USA). Despite this, the results show there was a large dif-
ference power measured using VO and CCV. The power
error varies considerably with acoustic power and cannot be
accounted for by adjusting the efficiency value, η.
For each measurement point, standard deviation of differ-
ence was calculated from the 4 repeat measurements made
with the RFB. Error from the electrical measurements was not
considered as it was several orders of magnitude smaller than
the error from the RFB. The standard deviation showed that the
variation in radiation force balance measurements contributed
less than ±6% error and typically less than 2%.
If the acoustic power is known, it is possible to predict
the pulse-average spatial-average intensity (ISAPA) by dividing
the total electrical power by the flux area of the beam. With
the H102 transducers, 40 W corresponds to an approximate
intensity of 3013 Wcm−2, meaning VO-measured power
measurement equates to a prediction error of +301 Wcm−2.
At the same acoustic power, substituting with CCV-measured
power could reduce this to -60 Wcm−2. For the 10-strip, 13
W corresponds to an intensity of 1207Wcm−2 which equates
to an error of -3669 Wcm−2 when VO is used. Again, this
could be reduced to +44Wcm−2 using CCV-measured power.
Above 20 W, acoustic streaming effects may contribute to
some of the error but this is expected to be minor compared to
experimental error. Despite the amplifier being a class-A type,
the variation in the VO-power is attributed to distortion in the
amplifier output and a variance in transducer acceptance with
voltage.
When square wave excitation was used (fig. 3) the VO-
measured power difference was also considerable (nominally
+300%). However, unlike the experiment which instead com-
pared transducers, the contributing factor here was the large
amount of reactive power at each of the harmonics in the
square wave.
The results show that CCV-measured power can compen-
sate for both harmonic distortion, reactance and reflections.
However, the usefulness of the technique as a predictor of
intensity does rely on η being constant, when in fact it is
known to change with both frequency and voltage. In terms
of frequency variance, equation 4 was made broadband to
include drive waveform distortion or harmonics generated
by the transducer. Since the real components will likely be
smaller than the central drive frequency, the impact of not
properly weighting η should be minor. Although predicting
acoustic power in the presence of drive-waveform distortion
is already greatly improved using the proposed technique,
drive circuitry distortion could be factored into the efficiency
calculation to improve the accuracy of the technique. The
proposed method controls effective electric power and there
are some circumstances this may sometimes not be exactly
relating to acoustic power, in particular, if the transducer
efficiency is affected. One limitation of the proposed technique
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Fig. 5. The efficiency of the three HIFU transducers as a function of input
voltage. H102-079 is approximately 6 months old and has seen very little use.
H102-065 has been used regularly over the past 6 years. In accordance with
the manufacture directions for the linear amplifier, 10-strip testing above 16
V was not conducted to protect the amplifier from reflected energy due to the
low impedance of the transducer.
is that it may not be possible to detect these issues if the
efficiency were to be affected. However, it is possible that in
an integrated system a lower effective electric power would be
obtained for the same driving voltage and this would indicate
damage, this should be explored in future work.
Efficiency variance with voltage was measured across a
range of peak voltages for all three transducers. For this test,
voltage was measured at the output of the linear amplifier
and the electrical power was measured using the proposed
technique. The linear amplifier (driven by a function gener-
ator) was used to minimise harmonic distortion in the drive
waveform. The results are shown in figure 5. It can be seen that
the older of the H102 transducers (H102-065) is approximately
10% less efficient than the newer one. Overall, η varied less
than 5% so will not have a big impact on the results.
The lesioning results (fig. 4) show that lesion volume
increases as the electrical power is increased. The lesions have
a nominal cross-sectional area of 14 mm2 at 16 W and 26
mm2 at 26 W.
When CCV was used to calibrate the circuits and subse-
quently perform lesioning, there was better agreement between
the lesion sizes. This can be quantified as follows: At 16 W the
lesions formed by the switched circuit had a mean 1.3 mm2
(10%) larger than when the the linear amplifier was used. At
26 W, the lesions had a mean 1.2 mm2 (5%) larger. However,
when VO-measured power was used to calibrate the circuits,
there was poor agreement between the lesion sizes: At 16(*)
W, the lesions formed using the switched circuit had a mean
5.0 mm2 smaller (38%) and at 26(*) W the mean was 6.5
mm2 (25%) larger.
As expected, there was an increase in lesion size as the
magnitude of the excitation parameters increased. Although at-
tempts were made to minimise the difference in power between
the switched and linear amplifier system using both power
measurement techniques, the relationship between the two
calibration schemes was not consistent across power levels.
Referring to I, with the switched system between 16(*) W
and 16 W there was a +3% difference in the calibration result.
However for the same system there was a -1% change between
26(*) W and 26 W. This inconsistency can be attributed to
higher-order harmonic content of the HRPWM waveforms
which is known to change with amplitude, and cannot be
compensated for without using the proposed technique. The
effect of this was that the difference between the switched
circuit and linear amplifier mean lesion size was negative at
16(*) W but was positive at 26(*) W.
The ANOVA results (table II) show that there is no statisti-
cally significant difference between the lesion sizes. However,
since the sample size is fixed, the pav values can be compared
which shows there is better agreement in the lesion size
when CCV was used at 16 W (0.55 > 0.13) and at 26 W
(0.72≫ 0.06). Only the minimum number of repeats required
to perform ANOVA analysis were performed, which reduces
the statistical power of the test. However, given that the effects
were observed at two different power levels, the probability
that type II error influenced the conclusion was low.
In the study, measurements were not made on the transducer
side of the matching network. It may have been more accurate
to instead measure the transducer side. However, since the
impedance was measured with the matching network in place
and the load attached, the only source of error should be
from insignificant heating losses in the network. The proposed
technique should work either side of the network. This is
important given that the matching network may or may not be
located near the driving electronics. At 10 W of acoustic power
using the H102-065, no discernable difference was observed
between post and pre-network measurements. Where matching
networks are not used, the clamp on current probe could be
replaced with a very low-loss MRI-compatible PCB Regowski
coil, or differential amplifier. Commercial systems may already
be implementing current monitoring on the power supply rails
of array systems, but this is not evident from current literature
and cannot discern differences in the properties of individual
elements in the array.
Just as with a RFB, predicting the resulting acoustic power
in the presence of bone or cavitation is complex. In transcranial
ultrasound, low frequencies ( < 1 MHz) are used and the skull
encompasses all of the transducer field so acoustic scattering
is fairly uniform and predictable. The proposed scheme will
be most suited to transcranial applications. For transcostal
applications, the interleaved nature of the rib cage means
that treatment planning remains a challenge. The proposed
technique may be useful in detecting cavitation however as
transducer impedance is known to change during cavitation
events [41].
Through the experiments with square wave excitation and
switched circuit lesioning, it has been shown that the technique
is highly immune to harmonic distortion. This is because
there is access to both voltage and current waveforms, so the
technique inherently compensates or the direction of flow at
all frequencies. Thus, the technique could be useful for class-
D HIFU systems and histrotripsy sources [53]. However, since
the latter is not a predominately thermal technique, acoustic
power may be less useful than peak positive pressure is. The
technique could be useful in the real time monitoring of lesion
formation.
Overall, the results show that VO-measured power can not
reliably be used to predict acoustic power and that the errors
8are sufficiently large enough to influence lesion size. These
errors are greatly reduced when using CCV-measured power
which produces lesions of consistent size.
VIII. CONCLUSIONS
Electrical power during HIFU therapy must be monitored to
avoid either under or overexposure and ensure patient safety.
In this paper it was shown that voltage monitoring alone is not
sufficient to monitor acoustic power. Instead combined voltage
and current monitoring, which could be integrated into drive
circuity, was combined to measure dissipated power.
The results showed that this technique can accurately predict
acoustic power. The use of current monitoring will facilitate
improvements in safety and practicality of HIFU systems, by
ensuring that acoustic power can be reliably controlled.
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